Demyelination News and Research

RSS
A demyelinating disease is any disease of the nervous system in which the myelin sheath of neurons is damaged. This impairs the conduction of signals in the affected nerves, causing impairment in sensation, movement, cognition, or other functions depending on which nerves are involved.
Cytokine interferon-gamma can be a disease-modifying therapeutic target in multiple system atrophy

Cytokine interferon-gamma can be a disease-modifying therapeutic target in multiple system atrophy

Widespread pain makes exercise a challenge for some patients with multiple sclerosis

Widespread pain makes exercise a challenge for some patients with multiple sclerosis

Abnormal myelin, not loss of myelin, may drive axon degeneration in myelin diseases

Abnormal myelin, not loss of myelin, may drive axon degeneration in myelin diseases

Dementia and cholesterol: investigating links and impacts of hormone replacement therapy

Dementia and cholesterol: investigating links and impacts of hormone replacement therapy

Advanced neuroimaging reveals surprising link between glaucoma and Alzheimer's disease

Advanced neuroimaging reveals surprising link between glaucoma and Alzheimer's disease

Exploring developmental pathways and disease interactions in nervous and stomatognathic systems

Exploring developmental pathways and disease interactions in nervous and stomatognathic systems

Study examines unimodal vs multimodal neuroimaging methods for classifying psychosis

Study examines unimodal vs multimodal neuroimaging methods for classifying psychosis

Researchers discover possible new biomarker of MS-like autoimmune disease

Researchers discover possible new biomarker of MS-like autoimmune disease

Can vitamin D have positive effects on reducing cortical pathology, oxidative stress, and neurofilament light chain serum levels?

Can vitamin D have positive effects on reducing cortical pathology, oxidative stress, and neurofilament light chain serum levels?

Multiple sclerosis: Immune cell invasion enabled by blood-brain barrier breakdown

Multiple sclerosis: Immune cell invasion enabled by blood-brain barrier breakdown

Cross-reactivity between Epstein-Barr virus and protein in multiple sclerosis sheds light on disease development

Cross-reactivity between Epstein-Barr virus and protein in multiple sclerosis sheds light on disease development

Research reveals a more effective treatment for multiple sclerosis patients

Research reveals a more effective treatment for multiple sclerosis patients

Criteria to assess for multiple sclerosis in adults may be insufficient for pediatric patients

Criteria to assess for multiple sclerosis in adults may be insufficient for pediatric patients

An overview of COVID-19-associated neurological complications in children

An overview of COVID-19-associated neurological complications in children

U of A researcher one step closer to demonstrating the potential of brain molecule to halt MS

U of A researcher one step closer to demonstrating the potential of brain molecule to halt MS

Pheno Therapeutics announces worldwide license from UCB to a novel program for neurodegenerative disease

Pheno Therapeutics announces worldwide license from UCB to a novel program for neurodegenerative disease

The spectrum of SARS-CoV-2–related neurologic involvement among children and adolescents in 2021

The spectrum of SARS-CoV-2–related neurologic involvement among children and adolescents in 2021

Treatment for neurological diseases often no longer effective enough in the later stages

Treatment for neurological diseases often no longer effective enough in the later stages

Neurological manifestations associated with monkeypox infection

Neurological manifestations associated with monkeypox infection

The currently available evidence on viral-induced parkinsonism

The currently available evidence on viral-induced parkinsonism